MedTrace Logo

Mini-AFTERc Intervention for Fear of Cancer Recurrence

NCT03763825 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 133

Last updated 2019-05-31

No results posted yet for this study

Summary

People treated for breast cancer often live with an ongoing fear that the cancer will recur. This fear may develop and impact on their mental health and quality of life. The Mini-AFTERc study is a pilot trial of a brief cognitive behavioural communication intervention, designed to reduce fear of cancer recurrence (FCR) in breast cancer patients. This pilot trial aims to determine the acceptability and practicality of introducing the Mini-AFTERc intervention into everyday practice, and inform the development of a full randomised controlled trial.

Conditions

Interventions

BEHAVIORAL

Mini-AFTERc

Structured 30-45 minute telephone discussion based on health psychology theory and CBT principles.

Sponsors & Collaborators

  • University of Stirling

    collaborator OTHER

  • University of Surrey

    collaborator OTHER

  • Swansea University

    collaborator OTHER

  • Chief Scientist Office of the Scottish Government

    collaborator OTHER_GOV

  • University of St Andrews

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-13
Primary Completion
2020-09-01
Completion
2020-09-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03763825 on ClinicalTrials.gov